Tianjin Tasly Pharmaceutical plans to use no more than 3 billion yuan of its own funds to purchase bank wealth management products.

Tianshili announced on September 17th that the company plans to use up to 3 billion yuan of idle funds to purchase low-risk and profitable financial products from banks and their subsidiary wealth management companies, as well as structured deposits from banks. The funds will not be directly invested in securities market products. The investment period is within one year from the date of approval by the shareholders' meeting, with a single investment period not exceeding six months.